vs
汉瑞祥（HSIC）与Ross Stores（ROST）财务数据对比。点击上方公司名可切换其他公司
Ross Stores的季度营收约是汉瑞祥的1.6倍（$5.6B vs $3.4B），Ross Stores净利率更高（9.1% vs 2.9%，领先6.2%），Ross Stores同比增速更快（10.4% vs 7.7%），Ross Stores自由现金流更多（$617.8M vs $338.0M），过去两年汉瑞祥的营收复合增速更高（4.1% vs -3.6%）
汉瑞祥（Henry Schein, Inc.）是美国的医疗保健产品及服务分销商，业务覆盖全球33个国家和地区，是全球面向诊所类牙科及医疗从业者的最大医疗解决方案供应商。公司连续14年入选Ethisphere评选的「全球最具道德企业」榜单，2025年再次登榜。
Ross Stores, Inc.是美国知名折扣百货连锁集团，旗下核心品牌为Ross Dress for Less，总部位于加利福尼亚州都柏林，是美国规模最大的平价零售商。截至2024年7月，集团在全美43个州、华盛顿特区、波多黎各及关岛共运营1795家门店，暂未覆盖新英格兰地区及阿拉斯加，另拥有门店数超353家的折扣零售品牌DD's Discounts。
HSIC vs ROST — 直观对比
营收规模更大
ROST
是对方的1.6倍
$3.4B
营收增速更快
ROST
高出2.7%
7.7%
净利率更高
ROST
高出6.2%
2.9%
自由现金流更多
ROST
多$279.8M
$338.0M
两年增速更快
HSIC
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.4B | $5.6B |
| 净利润 | $101.0M | $511.9M |
| 毛利率 | 30.9% | 28.0% |
| 营业利润率 | 4.7% | 11.6% |
| 净利率 | 2.9% | 9.1% |
| 营收同比 | 7.7% | 10.4% |
| 净利润同比 | 7.4% | 4.7% |
| 每股收益（稀释后） | $0.85 | $1.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HSICROST
| Q4 25 | $3.4B | $5.6B | ||
| Q3 25 | $3.3B | $5.5B | ||
| Q2 25 | $3.2B | $5.0B | ||
| Q1 25 | $3.2B | $5.9B | ||
| Q4 24 | $3.2B | $5.1B | ||
| Q3 24 | $3.2B | $5.3B | ||
| Q2 24 | $3.1B | $4.9B | ||
| Q1 24 | $3.2B | $6.0B |
净利润HSICROST
| Q4 25 | $101.0M | $511.9M | ||
| Q3 25 | $101.0M | $508.0M | ||
| Q2 25 | $86.0M | $479.2M | ||
| Q1 25 | $110.0M | $586.8M | ||
| Q4 24 | $94.0M | $488.8M | ||
| Q3 24 | $99.0M | $527.1M | ||
| Q2 24 | $104.0M | $488.0M | ||
| Q1 24 | $93.0M | $609.7M |
毛利率HSICROST
| Q4 25 | 30.9% | 28.0% | ||
| Q3 25 | 30.7% | 27.6% | ||
| Q2 25 | 31.4% | 28.2% | ||
| Q1 25 | 31.6% | 26.5% | ||
| Q4 24 | 31.1% | 28.3% | ||
| Q3 24 | 31.3% | 28.3% | ||
| Q2 24 | 32.5% | 28.1% | ||
| Q1 24 | 31.9% | 27.3% |
营业利润率HSICROST
| Q4 25 | 4.7% | 11.6% | ||
| Q3 25 | 4.9% | 11.5% | ||
| Q2 25 | 4.7% | 12.2% | ||
| Q1 25 | 5.5% | 12.4% | ||
| Q4 24 | 4.9% | 11.9% | ||
| Q3 24 | 4.9% | 12.5% | ||
| Q2 24 | 5.1% | 12.2% | ||
| Q1 24 | 4.7% | 13.2% |
净利率HSICROST
| Q4 25 | 2.9% | 9.1% | ||
| Q3 25 | 3.0% | 9.2% | ||
| Q2 25 | 2.7% | 9.6% | ||
| Q1 25 | 3.5% | 9.9% | ||
| Q4 24 | 2.9% | 9.6% | ||
| Q3 24 | 3.1% | 10.0% | ||
| Q2 24 | 3.3% | 10.0% | ||
| Q1 24 | 2.9% | 10.1% |
每股收益（稀释后）HSICROST
| Q4 25 | $0.85 | $1.58 | ||
| Q3 25 | $0.84 | $1.56 | ||
| Q2 25 | $0.70 | $1.47 | ||
| Q1 25 | $0.88 | $1.79 | ||
| Q4 24 | $0.75 | $1.48 | ||
| Q3 24 | $0.78 | $1.59 | ||
| Q2 24 | $0.80 | $1.46 | ||
| Q1 24 | $0.72 | $1.82 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $156.0M | $4.1B |
| 总债务越低越好 | $2.3B | $1.5B |
| 股东权益账面价值 | $3.2B | $5.9B |
| 总资产 | $11.2B | $15.4B |
| 负债/权益比越低杠杆越低 | 0.71× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资HSICROST
| Q4 25 | $156.0M | $4.1B | ||
| Q3 25 | $136.0M | $3.8B | ||
| Q2 25 | $145.0M | $3.8B | ||
| Q1 25 | $127.0M | $4.7B | ||
| Q4 24 | $122.0M | $4.3B | ||
| Q3 24 | $126.0M | $4.7B | ||
| Q2 24 | $138.0M | $4.7B | ||
| Q1 24 | $159.0M | $4.9B |
总债务HSICROST
| Q4 25 | $2.3B | $1.5B | ||
| Q3 25 | $2.2B | $1.5B | ||
| Q2 25 | $2.1B | $1.5B | ||
| Q1 25 | $2.0B | $2.2B | ||
| Q4 24 | $1.8B | $2.2B | ||
| Q3 24 | $1.9B | $2.5B | ||
| Q2 24 | $1.9B | $2.5B | ||
| Q1 24 | $2.0B | $2.5B |
股东权益HSICROST
| Q4 25 | $3.2B | $5.9B | ||
| Q3 25 | $3.4B | $5.7B | ||
| Q2 25 | $3.4B | $5.6B | ||
| Q1 25 | $3.3B | $5.5B | ||
| Q4 24 | $3.4B | $5.3B | ||
| Q3 24 | $3.5B | $5.1B | ||
| Q2 24 | $3.5B | $4.9B | ||
| Q1 24 | $3.6B | $4.9B |
总资产HSICROST
| Q4 25 | $11.2B | $15.4B | ||
| Q3 25 | $11.1B | $14.5B | ||
| Q2 25 | $10.9B | $14.3B | ||
| Q1 25 | $10.5B | $14.9B | ||
| Q4 24 | $10.2B | $14.9B | ||
| Q3 24 | $10.6B | $14.7B | ||
| Q2 24 | $10.3B | $14.5B | ||
| Q1 24 | $10.1B | $14.3B |
负债/权益比HSICROST
| Q4 25 | 0.71× | 0.26× | ||
| Q3 25 | 0.64× | 0.26× | ||
| Q2 25 | 0.61× | 0.27× | ||
| Q1 25 | 0.59× | 0.40× | ||
| Q4 24 | 0.54× | 0.42× | ||
| Q3 24 | 0.54× | 0.48× | ||
| Q2 24 | 0.54× | 0.50× | ||
| Q1 24 | 0.56× | 0.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $381.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $338.0M | $617.8M |
| 自由现金流率自由现金流/营收 | 9.8% | 11.0% |
| 资本支出强度资本支出/营收 | 1.3% | 3.7% |
| 现金转化率经营现金流/净利润 | 3.77× | 1.62× |
| 过去12个月自由现金流最近4个季度 | $573.0M | $2.0B |
8季度趋势，按日历期对齐
经营现金流HSICROST
| Q4 25 | $381.0M | $827.1M | ||
| Q3 25 | $174.0M | $668.4M | ||
| Q2 25 | $120.0M | $409.7M | ||
| Q1 25 | $37.0M | $882.6M | ||
| Q4 24 | $204.0M | $513.4M | ||
| Q3 24 | $151.0M | $592.1M | ||
| Q2 24 | $296.0M | $368.9M | ||
| Q1 24 | $197.0M | $948.8M |
自由现金流HSICROST
| Q4 25 | $338.0M | $617.8M | ||
| Q3 25 | $141.0M | $466.6M | ||
| Q2 25 | $88.0M | $202.3M | ||
| Q1 25 | $6.0M | $676.6M | ||
| Q4 24 | $168.0M | $333.0M | ||
| Q3 24 | $117.0M | $394.6M | ||
| Q2 24 | $259.0M | $232.7M | ||
| Q1 24 | $156.0M | $726.4M |
自由现金流率HSICROST
| Q4 25 | 9.8% | 11.0% | ||
| Q3 25 | 4.2% | 8.4% | ||
| Q2 25 | 2.7% | 4.1% | ||
| Q1 25 | 0.2% | 11.4% | ||
| Q4 24 | 5.3% | 6.6% | ||
| Q3 24 | 3.7% | 7.5% | ||
| Q2 24 | 8.3% | 4.8% | ||
| Q1 24 | 4.9% | 12.1% |
资本支出强度HSICROST
| Q4 25 | 1.3% | 3.7% | ||
| Q3 25 | 1.0% | 3.6% | ||
| Q2 25 | 1.0% | 4.2% | ||
| Q1 25 | 1.0% | 3.5% | ||
| Q4 24 | 1.1% | 3.6% | ||
| Q3 24 | 1.1% | 3.7% | ||
| Q2 24 | 1.2% | 2.8% | ||
| Q1 24 | 1.3% | 3.7% |
现金转化率HSICROST
| Q4 25 | 3.77× | 1.62× | ||
| Q3 25 | 1.72× | 1.32× | ||
| Q2 25 | 1.40× | 0.85× | ||
| Q1 25 | 0.34× | 1.50× | ||
| Q4 24 | 2.17× | 1.05× | ||
| Q3 24 | 1.53× | 1.12× | ||
| Q2 24 | 2.85× | 0.76× | ||
| Q1 24 | 2.12× | 1.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HSIC
| Global Dental Merchandise | $1.2B | 35% |
| Global Medical | $1.1B | 31% |
| Global Dental Equipment | $536.0M | 16% |
| Global Specialty Products | $422.0M | 12% |
| Global Technology | $173.0M | 5% |
| Global Value Added Services | $64.0M | 2% |
| Equity Method Investee | $14.0M | 0% |
ROST
暂无分部数据
